Ondine Biomedical
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Ondine Biomedical sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Ondine Biomedical: 3 sponsored US clinical trials, 1 recruiting.
Ondine Biomedical sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anti-Infective Agents, with 1 trials.
Upper-quartile sponsor footprint
Ondine Biomedical sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
NCT06702878
Red Light Photobiomodulation and Topical Disinfectants
NCT05797818
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
NCT05090657
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the Ondine Biomedical pipeline
1 recruiting of 3 indexed (33% open); 2 completed (67%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Anti-Infective Agents (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ondine Biomedical: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Ondine Biomedical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Ondine Biomedical page
3 registered trials is a research-attention snapshot, not an endorsement of Ondine Biomedical or any single study.
- 1 of Ondine Biomedical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anti-Infective Agents is the condition Ondine Biomedical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anti-Infective Agents trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ondine Biomedical pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.